Miami-based Nicklaus Children’s Hospital’s Heart Institute has become the first in South Florida to offer the FDA-approved Minima stent, a first-of-its-kind cardiac heart stent designed to expand as a child grows, according to an Aug. 28 system news release.
Developed by Newport Beach. Calif.-based Renata Medical, the stent system is built for children with congenital heart disease to address conditions such as coarctation of the aorta and branch pulmonary stenosis. Unlike adult stents, it can be safely dilated over time to reach adult size, reducing the need for repeated open-heart surgeries.
“This represents a new era in how we care for children with congenital heart disease,” said Daniel Duarte Caceres, MD, congenital interventional cardiologist and medical director of interventional cardiology at Nicklaus Children’s, in the release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
